Literature DB >> 6810522

Serologic considerations in donor-specific transfusion therapy for kidney transplantation.

R Schweizer, L Bow, D Generas, S Bartus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6810522

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

1.  Donor-specific blood transfusions.

Authors: 
Journal:  West J Med       Date:  1983-03

2.  Induction of anti-allo-class I H-2 tolerance by inactivation of CD8+ helper T cells, and reversal of tolerance through introduction of third-party helper T cells.

Authors:  S Kitagawa; S Sato; S Hori; T Hamaoka; H Fujiwara
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

3.  Cell-cell interaction in graft rejection responses: induction of anti-allo-class I H-2 tolerance is prevented by immune responses against allo-class II H-2 antigens coexpressed on tolerogen.

Authors:  S Hori; S Kitagawa; H Iwata; T Ochiai; K Isono; T Hamaoka; H Fujiwara
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

4.  Heterogenous graft rejection pathways in class I major histocompatibility complex-disparate combinations and their differential susceptibility to immunomodulation induced by intravenous presensitization with relevant alloantigens.

Authors:  S Kitagawa; H Iwata; S Sato; J Shimizu; T Hamaoka; H Fujiwara
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.